Virus-specific memory T cells populate tumors and can be repurposed for tumor immunotherapy
The immunosuppressive tumor environment and the lack of functional anti-tumor immunity are major limiting factors in immunotherapy. Here the authors show that human and mouse tumors are infiltrated by virus-specific memory T cells, which can be harnessed by viral peptides to induce local and systemi...
Main Authors: | Pamela C. Rosato, Sathi Wijeyesinghe, J. Michael Stolley, Christine E. Nelson, Rachel L. Davis, Luke S. Manlove, Christopher A. Pennell, Bruce R. Blazar, Clark C. Chen, Melissa A. Geller, Vaiva Vezys, David Masopust |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2019-02-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-019-08534-1 |
Similar Items
-
The “Trojan Horse” Approach to Tumor Immunotherapy: Targeting the Tumor Microenvironment
by: Delia Nelson, et al.
Published: (2014-01-01) -
Robust Iterative Stimulation with Self-Antigens Overcomes CD8+ T Cell Tolerance to Self- and Tumor Antigens
by: Christine E. Nelson, et al.
Published: (2019-09-01) -
The Role of Membrane Bound Complement Regulatory Proteins in Tumor Development and Cancer Immunotherapy
by: Anne Geller, et al.
Published: (2019-05-01) -
Repurposing the yellow fever vaccine for intratumoral immunotherapy
by: Maria Angela Aznar, et al.
Published: (2020-01-01) -
Repurposing infectious disease vaccines for intratumoral immunotherapy
by: Christophe Caux, et al.
Published: (2020-06-01)